Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avicanna Inc T.AVCN

Alternate Symbol(s):  AVCNF

Healthcare Cannabis
Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including oral, sublingual, topical and transdermal delivery. It has developed a pipeline of patent-pending drug candidates that are indication specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain and various neurological disorders. Its first pharmaceutical preparation (Trunerox) is in the drug registration stage in South America. MyMedi.ca is a medical cannabis care platform that serves medical cannabis patients’ needs and enhances the patient's journey.


TSX:AVCN - Post by User

Avicanna Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(66)
•••
Post by Shaft4300on Mar 31, 2022 7:28pm
248 Views
Post# 34565086

WOW

WOW
IT IS EMBARASSING TO STILL HAVE THIS GUY AS CEO OF THIS COMPANY. WE NEED CHANGE NOW OR WE WILL BE SHORTED TO ZERO..THIS MAN IS NO GOOD AND AS A SHAREHOLDER HE HAS TO GO...HE HAS NO RESPECT OR VALUE SHAREHOLDERS WHO PAID HIS SALARY AND SENT HIM ON ALL THOSE TRIPS THAT HAS YIELDED NADA...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities